| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kwok Keung Lit, Zhamilya Zhirenova, Anna Block. Insulin-like growth factor-binding protein 7 (IGFBP7): A microenvironment-dependent regulator of angiogenesis and vascular remodeling. Frontiers in cell and developmental biology. vol 12. 2024-07-24. PMID:39045455. |
insulin-like growth factor-binding protein 7 (igfbp7) is an extracellular matrix (ecm) glycoprotein, highly enriched in activated vasculature during development, physiological and pathological tissue remodeling. |
2024-07-24 |
2024-07-26 |
Not clear |
| Sarah M Shoeib, Asmaa Hassan, Eman Habeeb, Rasha Abdallah Ragab, Sara Elakshar, Dalia Sherie. Urinary Insulin-Like Growth Factor-Binding Protein 7 (IGFBp7), Urinary Tissue Inhibitor of Matrix Metalloproteinase 2 (TIMP2), and Serum Transgelin as Novel Biomarkers of Kidney Injury in Multiple Myeloma. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion. vol 40. issue 2. 2024-05-06. PMID:38708150. |
urinary insulin-like growth factor-binding protein 7 (igfbp7), urinary tissue inhibitor of matrix metalloproteinase 2 (timp2), and serum transgelin as novel biomarkers of kidney injury in multiple myeloma. |
2024-05-06 |
2024-05-08 |
Not clear |
| Moritz Schanz, Martin Kimmel, Mark Dominik Alscher, Kerstin Amann, Christoph Danie. TIMP-2 and IGFBP7 in human kidney biopsies in renal disease. Clinical kidney journal. vol 16. issue 9. 2023-09-04. PMID:37664566. |
tissue inhibitor of matrix metalloproteinase-2 (timp-2) and insulin-like growth factor binding protein 7 (igfbp7) are markers of tubular stress and urinary [timp-2]*[igfbp7] is an established biomarker for risk assessment of acute kidney injury. |
2023-09-04 |
2023-09-07 |
human |
| Chao Liu, Zi-Qing Gao, Juan Li, Qi Zho. Identification of novel therapeutic targets for Fuchs' endothelial corneal dystrophy based on gene bioinformatics analysis. PloS one. vol 17. issue 3. 2022-03-03. PMID:35239706. |
both collagen-containing extracellular matrix and extracellular matrix hit to anxa1, vcan, gpc3, tnc, igfbp7, matn3, and sparcl1 genes in the go cellular components. |
2022-03-03 |
2023-08-13 |
Not clear |
| Katarzyna Hetmańczyk-Sawicka, Roksana Iwanicka-Nowicka, Anna Fogtman, Jarosław Cieśla, Paweł Włodarski, Barbara Żyżyńska-Granica, Mirella Filocamo, Andrea Dardis, Paolo Peruzzo, Małgorzata Bednarska-Makaruk, Marta Koblowska, Agnieszka Ługowsk. Changes in global gene expression indicate disordered autophagy, apoptosis and inflammatory processes and downregulation of cytoskeletal signalling and neuronal development in patients with Niemann-Pick C disease. Neurogenetics. vol 21. issue 2. 2021-05-27. PMID:31927669. |
downregulated genes were associated with cytoskeletal signalling (actg2, cnn1); inflammation and oxidative stress (cnn1); inhibition of cell proliferation, migration and differentiation; erk-mapk pathway (col4a1, col4a2, cpa4); cell adhesion (igfbp7); autophagy and apoptosis (cdh2, igfbp7, col4a2); neuronal function and development (csrp1); and extracellular matrix stability (plod2). |
2021-05-27 |
2023-08-13 |
Not clear |
| Barbara Bellei, Angela Pitisci, Monica Ottaviani, Matteo Ludovici, Carlo Cota, Fabiola Luzi, Maria Lucia Dell'Anna, Mauro Picard. Vitiligo: a possible model of degenerative diseases. PloS one. vol 8. issue 3. 2014-01-07. PMID:23555779. |
moreover, vitiligo melanocytes produced many biologically active proteins among the senescence-associated secretory phenotype (saps), such as interleukin-6 (il-6), matrix metallo proteinase-3 (mmp3), cyclooxygenase-2 (cox-2), insulin-like growth factor-binding protein-3 and 7 (igfbp3, igfbp7). |
2014-01-07 |
2023-08-12 |
Not clear |
| Derek J Nancarrow, Andrew D Clouston, B Mark Smithers, David C Gotley, Paul A Drew, David I Watson, Sonika Tyagi, Nicholas K Hayward, David C Whitema. Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma. PloS one. vol 6. issue 7. 2011-12-06. PMID:21829465. |
eac exhibits the enhanced extracellular matrix remodeling (collagens, igfbp7, plau) effects expected in an aggressive form of cancer, as well as evidence of reduced expression of genes associated with mucosal (muc6, ca2, tff1) and xenobiotic (akr1c2, akr1b10) defenses. |
2011-12-06 |
2023-08-12 |
Not clear |